Journal of Alzheimer’s Disease
- ISSN
- 1387-2877
- Volume
- 28-32; 20 issues
- Status
- Last issue (28:2) online on 25 January 2012
- Next issue
- 28:3 scheduled for February 2012
- Back volumes
- 1-22
- Website
- www.j-alz.com
- Subject
- Neurosciences
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor.
The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
In Remembrance of Editor-in-Chief Mark A. Smith
Click here to read JAD's article on the top 100 researchers in Alzheimer's Disease, free of charge.
Editors-in-Chief
George Perry, PhD
University of Texas at San Antonio College of Sciences One UTSA Circle San Antonio, TX 78249 USA Tel.: +1 210 458 4450 Fax:+1 210 458 4445 Email: george.perry@utsa.edu Mark A. Smith PhD †
Case Western Reserve University Department of Pathology 2103 Cornell Road Cleveland, OH 44106 USA Tel.: +1 216 368 3670 Fax:+1 216 368 8964 Email: mark.smith@case.edu Reviews Editor Jesús Ávila MD Centro de Biología Molecular 'Severo Ochoa' Universidad Autónoma de Madrid C/Nicolás Cabrera, 1 28049 Madrid Spain Tel.: +34 91 196 45 64 Fax:+34 91 196 44 20 Email: javila@cbm.uam.es Clinical Editor
J. Wesson Ashford MD, PhD
Stanford / VA Aging Clinical Research Center VA Palo Alto Health Care System - 151-Y 3801 Miranda Avenue Palo Alto, CA 94304 USA Tel.: +1 650 852 3287 Fax:+1 650 852 03297 Email: ashford@stanford.edu Assistant Clinical Editor
Massimo Tabaton, MD Dept. of Neuroscience, Ophthalmology and Genetics University of Genova Via De Toni, 5
16132 Genova
Italy
Tel: 0039 010 3537064 Fax: 0039 010 506938 Email: mtabaton@neurologia.unige.it
Scientometrics Editor
Aaron A. Sorenson Collexis Holdings, Inc. 1201 Main Street, Suite 980 Columbia, SC 29201 USA Tel.: +1 803 727 1113 Email: sorenson@collexia.com Managing Editor Bethany Kumar Department of Pathology Case Western Reserve University 2103 Cornell Road Cleveland, OH 44106 USA Tel.: +1 216 368 2488 Fax:+1 216 368 8964 Email: editorial@j-alz.com Senior Editors
Amalia Bruni
Italy Allan Butterfield Gemma Casadesus Suzanne De La Monte Jack De La Torre Alexandre De Mendonca Daniela Galimberti Othman Ghribi Chengxin Gong Ralph Martins Patrizia Mecocci Sigfrido Scarpa Alessandro Serretti Thomas B. Shea Xiongwei Zhu
| For details on the editorial board, please check out www.j-alz.com. |
Biological Abstracts
BIOSIS Previews
CAB Abstracts
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illumina
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
E-Psyche database
EBSCO database
EBSCO Databases
Embase
EMCare
Index Copernicus
Index Medicus
Journal Citation Reports/Science Edition
MEDLINE
Neuroscience Citation Index®
Prous Science Integrity
PsychInfo
PsycINFO
Pubmed
PubsHub
Science Citation Index-Expanded (SciSearch®)
SciVerse Scopus
Ulrich's Periodicals Directory
08 March 2012 - 11 March 2012
Vienna
Austria
8th International Congress On Mental Dysfunction & Other Non-Motor Features In Parkinson's Disease and Related Disorders
03 May 2012 - 06 May 2012
Berlin
Germany
New Study Challenges Accepted Approaches to Research in Senile Dementia (Alzheimer’s Disease)
07 Nov 2011 - Amsterdam, NL, 7 November 2011 – Impacting millions of families and devouring billions of dollars globally, Alzheimer’s disease is the focus of exhaustive research to find a cure. Although intensely investigated over the last three decades using cutting-edge technologies, the “pathogenic cause” of Alzheimer’s disease has not been found. While many research “breakthroughs” have been...
Could hypertension drugs help people with Alzheimer’s?
19 Oct 2011 - Within the next 20 years it is expected the number of people with Alzheimer’s disease (AD) will double from its current figure of half a million to one million. A new study has looked at whether certain types of drugs used to treat high blood pressure, also called hypertension, might have beneficial effects in reducing the number of new cases of Alzheimer’s disease each year. ...
Advances in Brain Imaging Can Expedite Research and Diagnosis in Alzheimer’s Disease
11 Oct 2011 - Alzheimer’s disease (AD) is a common problem that is becoming progressively burdensome throughout the world. A new supplement to the Journal of Alzheimer’s Disease, Imaging the Alzheimer Brain, clearly shows that multiple imaging systems are now available to help understand, diagnose, and treat the disease. ...
Blood tests may hold clues to pace of alzheimer’s disease progression
04 Oct 2011 - A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer’s disease (AD) will lose cognitive function by looking at ratios of two fatty compounds in their blood. The finding, they say, could provide useful information to families and caregivers, and might also suggest treatment targets for this heartbreaking and incurab...
Scientists uncover new clues to Alzheimer’s risk gene that affects one in six
07 Sep 2011 - UK scientists have uncovered how a known risk gene for Alzheimer’s might play a role in the development of the disease. The study – which was funded by Alzheimer’s Society and Alzheimer’s Research UK – provides an exciting new area of investigation for researchers developing treatments and ultimately a cure for the disease. It is being published in the current issue of the Journal of Alz...